期刊文献+

原发性卵巢Burkitt淋巴瘤病理分析1例并文献复习 被引量:4

Pathological analysis of primary ovarian Burkitt lymphoma:a case report and literature review
下载PDF
导出
摘要 目的:为了更好地认识原发性卵巢Burkitt淋巴瘤(Burkitt's lymphoma,BL)的临床表现、病理特征及其预后。方法:收集1例原发性卵巢BL的病例及其参考文献资料,观察其临床表现、临床病理学特征、免疫组织化学染色及1年的预后。结果:原发性卵巢BL临床表现主要为腹部或盆腔肿块,镜下可见肿瘤细胞弥漫增生,主要由淋巴样细胞组成,细胞中等大小,弥漫生长,细胞核圆形或卵圆形,染色质粗块状,核仁中等大小,嗜碱性,其中散在巨噬细胞,成"星空现象",免疫组织化学结果显示:CD79a(+),CD20(+),CD3(–),CD10(+),BCL-6(+),BCL2(–)和Ki-67(>90%)。结论:诊断原发性卵巢BL需结合组织学及免疫组织化学结果,并对其鉴别诊断加以区分。 Objective:To have a better understanding of the clinical manifestations,pathological features and prognosis of primary ovarian Burkitt lymphoma(BL).Methods:A primary ovarian BL case and pertinent literature were collected,the clinical manifestations,pathological features,immunohistochemical staining and 1 year prognosis were observed.Results:The main clinical manifestations of primary ovarian BL were abdominal or pelvic masses,microscopically tumor cells diffuse hyperplasia,mainly composed of lymphoid cells,medium size cells,diffuse growth,round or oval nuclei,coarse chromatin,medium size nucleolus,and basophilic;the macrophages were scattered and distributed into "star phenomenon" under microscope.Immunohistochemical results were:CD79a(+),CD20(+),CD3(–),CD10(+),BCL-6(+),BCL2(–),and Ki-67(〉90%).Conclusion:The diagnosis of primary BL should be combined with histological and immunohistochemical findings,and the differential diagnosis should be distinguished.
作者 纪青 苏俊 邓飞 jI Qing SU Jun DENG Fei(Department of Pathology, Zunyi Medical College, Zunyi Guizhou 563000, Chin)
出处 《临床与病理杂志》 2017年第3期632-636,共5页 Journal of Clinical and Pathological Research
关键词 原发性卵巢Burkitt淋巴瘤 临床表现 病理特征 免疫组织化学 预后 primary ovarian Burkitt lymphoma clinical manifestations pathologic features immunohistochemistry prognosis
  • 相关文献

参考文献2

二级参考文献24

  • 1王文福,孙蕊,赵霞玉,李玉芝.卵巢及子宫颈恶性淋巴瘤10例临床分析[J].中华妇产科杂志,1994,29(1):23-26. 被引量:25
  • 2CrastaJA, Vallikad E. Ovarian lymphoma. Indian[J]. Med Paediatr Oncol, 2009, 30(1):28-30.
  • 3Crawshaw J, Sohaib SA, Wotherspoon A, et al. Primary non- Hodgkin's lymphoma of the ovaries: imaging fmdings[J]. BrJ Radi- ol, 2007, 80(956):155-158.
  • 4Chishima F, Hayakawa S, Ohta Y, et al. Ovarian Burkitt's lympho- ma diagnosed by a combination of clinical features, morphology, immunophenotype, and molecular findings and successfully man- aged with surgery and chemotherapy[J]. Gynecol Cancer, 2006, 16 (1):337-343.
  • 5Vang R, Jeffrey Medeiros L, Warnke RA, et al. Ovarian Non- Hodgkin's lymphoma: A clinicopathologic study of eight primary cases[J]. Mod Pathol, 2001, 14(11):1093-1099.
  • 6Takei T, Uchiyama M. Primary ovarian non-Hodgkin's lympho- ma[J]. BMJ Case Rep, 2013,Ju129:2013.
  • 7Koksal Y, Caliskan U, Ucar C, et al. A case of primary ovari- an lymphoma in a child with high levels of CA125 and CA19-9[J]. Pediatr Hematol Oncol, 2005 Nov, 27(11):594-595.
  • 8Arnogiarmaki N, Grigoriadis C, Zygouris D. Primary ovari- an non-Hodgkin's lymphoma[J]. EurJ Gynaecol Oncol, 2011, 32(4): 441-442.
  • 9Bianchi P, Torcia F, Vitali M, et al. An atypical presentation of spo- radic ovarian Burkitt's lymphoma: case report and review of the lit- erature[J]. Ovarian Res, 2013, 6(1):46.
  • 10Signorelli M, Maneo A, Cammarota S, et al. Conservative manage- ment in primary genital lymphomas: The role of chemotherapy[J]. Gynecol Oncol, 2007, 104(2):416.

共引文献10

同被引文献19

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部